Inspire Medical Systems Quarterly Income Statements Chart
Quarterly
|
Annual
Inspire Medical Systems Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue | 217,086,000 | 201,317,000 | 239,718,000 | 203,191,000 | 195,885,000 | 164,010,000 | 192,508,000 | 153,302,000 | 151,092,000 | 127,897,000 | 137,900,000 | 109,188,000 | 91,386,000 | 69,382,000 | 78,398,000 | 61,685,000 | 52,959,000 | 40,352,000 | 46,009,000 | 35,842,000 | 12,183,000 | 21,347,000 | 26,906,000 | 20,862,000 | 18,032,000 | 16,250,000 | 16,559,000 | 13,054,000 |
| yoy | 10.82% | 22.75% | 24.52% | 32.54% | 29.65% | 28.24% | 39.60% | 40.40% | 65.33% | 84.34% | 75.90% | 77.01% | 72.56% | 71.94% | 70.40% | 72.10% | 334.70% | 89.03% | 71.00% | 71.81% | -32.44% | 31.37% | 62.49% | 59.81% | ||||
| qoq | 7.83% | -16.02% | 17.98% | 3.73% | 19.43% | -14.80% | 25.57% | 1.46% | 18.14% | -7.25% | 26.30% | 19.48% | 31.71% | -11.50% | 27.09% | 16.48% | 31.24% | -12.30% | 28.37% | 194.20% | -42.93% | -20.66% | 28.97% | 15.69% | 10.97% | -1.87% | 26.85% | |
| cost of goods sold | 34,672,000 | 30,709,000 | 35,988,000 | 32,398,000 | 29,843,000 | 24,757,000 | 28,054,000 | 24,382,000 | 24,252,000 | 19,888,000 | 22,152,000 | 19,786,000 | 14,173,000 | 10,004,000 | 11,156,000 | 8,624,000 | 7,518,000 | 5,981,000 | 7,161,000 | 5,211,000 | 1,954,000 | 3,297,000 | 4,239,000 | 3,456,000 | 3,094,000 | 2,854,000 | 3,193,000 | 2,467,000 |
| gross profit | 182,414,000 | 170,608,000 | 203,730,000 | 170,793,000 | 166,042,000 | 139,253,000 | 164,454,000 | 128,920,000 | 126,840,000 | 108,009,000 | 115,748,000 | 89,402,000 | 77,213,000 | 59,378,000 | 67,242,000 | 53,061,000 | 45,441,000 | 34,371,000 | 38,848,000 | 30,631,000 | 10,229,000 | 18,050,000 | 22,667,000 | 17,406,000 | 14,938,000 | 13,396,000 | 13,366,000 | 10,587,000 |
| yoy | 9.86% | 22.52% | 23.88% | 32.48% | 30.91% | 28.93% | 42.08% | 44.20% | 64.27% | 81.90% | 72.14% | 68.49% | 69.92% | 72.76% | 73.09% | 73.23% | 344.24% | 90.42% | 71.39% | 75.98% | -31.52% | 34.74% | 69.59% | 64.41% | ||||
| qoq | 6.92% | -16.26% | 19.28% | 2.86% | 19.24% | -15.32% | 27.56% | 1.64% | 17.43% | -6.69% | 29.47% | 15.79% | 30.04% | -11.70% | 26.73% | 16.77% | 32.21% | -11.52% | 26.83% | 199.45% | -43.33% | -20.37% | 30.23% | 16.52% | 11.51% | 0.22% | 26.25% | |
| gross margin % | 84.03% | 84.75% | 84.99% | 84.06% | 84.77% | 84.91% | 85.43% | 84.10% | 83.95% | 84.45% | 83.94% | 81.88% | 84.49% | 85.58% | 85.77% | 86.02% | 85.80% | 85.18% | 84.44% | 85.46% | 83.96% | 84.56% | 84.25% | 83.43% | 82.84% | 82.44% | 80.72% | 81.10% |
| operating expenses: | ||||||||||||||||||||||||||||
| research and development | 26,209,000 | 27,803,000 | 30,336,000 | 26,083,000 | 28,859,000 | 28,850,000 | 31,052,000 | 29,144,000 | 30,821,000 | 25,519,000 | 21,248,000 | 20,993,000 | 14,534,000 | 11,870,000 | 10,294,000 | 9,614,000 | 9,288,000 | 8,154,000 | 7,285,000 | 7,307,000 | 6,062,000 | 5,438,000 | 3,767,000 | 3,623,000 | 2,846,000 | 2,603,000 | 2,152,000 | 1,771,000 |
| selling, general and administrative | 159,521,000 | 144,290,000 | 141,510,000 | 130,392,000 | 132,084,000 | 125,621,000 | 124,105,000 | 113,247,000 | 112,618,000 | 101,988,000 | 94,835,000 | 85,603,000 | 76,686,000 | 63,564,000 | 58,769,000 | 53,243,000 | 48,697,000 | 41,906,000 | 38,625,000 | 33,216,000 | 26,981,000 | 29,052,000 | 28,193,000 | 22,434,000 | 20,268,000 | 19,570,000 | ||
| total operating expenses | 185,730,000 | 172,093,000 | 171,846,000 | 156,475,000 | 160,943,000 | 154,471,000 | 155,157,000 | 142,391,000 | 143,439,000 | 127,507,000 | 116,083,000 | 106,596,000 | 91,220,000 | 75,434,000 | 69,063,000 | 62,857,000 | 57,985,000 | 50,060,000 | 45,910,000 | 40,523,000 | 33,043,000 | 34,490,000 | 31,960,000 | 26,057,000 | 23,114,000 | 22,173,000 | 18,263,000 | 15,236,000 |
| operating income | -3,316,000 | -1,485,000 | 31,884,000 | 14,318,000 | 5,099,000 | -15,218,000 | 9,297,000 | -13,471,000 | -16,599,000 | -19,498,000 | -335,000 | -17,194,000 | -14,007,000 | -16,056,000 | -1,821,000 | -9,796,000 | -12,544,000 | -15,689,000 | -7,062,000 | -9,892,000 | -22,814,000 | -16,440,000 | -9,293,000 | -8,651,000 | -8,176,000 | -8,777,000 | -4,897,000 | -4,649,000 |
| yoy | -165.03% | -90.24% | 242.95% | -206.29% | -130.72% | -21.95% | -2875.22% | -21.65% | 18.51% | 21.44% | -81.60% | 75.52% | 11.66% | 2.34% | -74.21% | -0.97% | -45.02% | -4.57% | -24.01% | 14.35% | 179.04% | 87.31% | 89.77% | 86.08% | ||||
| qoq | 123.30% | -104.66% | 122.68% | 180.80% | -133.51% | -263.69% | -169.01% | -18.84% | -14.87% | 5720.30% | -98.05% | 22.75% | -12.76% | 781.71% | -81.41% | -21.91% | -20.05% | 122.16% | -28.61% | -56.64% | 38.77% | 76.91% | 7.42% | 5.81% | -6.85% | 79.23% | 5.33% | |
| operating margin % | -1.53% | -0.74% | 13.30% | 7.05% | 2.60% | -9.28% | 4.83% | -8.79% | -10.99% | -15.25% | -0.24% | -15.75% | -15.33% | -23.14% | -2.32% | -15.88% | -23.69% | -38.88% | -15.35% | -27.60% | -187.26% | -77.01% | -34.54% | -41.47% | -45.34% | -54.01% | -29.57% | -35.61% |
| other income: | ||||||||||||||||||||||||||||
| interest and dividend income | -4,486,000 | -5,066,000 | -5,552,000 | -5,890,000 | -5,882,000 | -5,923,000 | -5,870,000 | -5,495,000 | -4,922,000 | -4,273,000 | -3,369,000 | -1,350,000 | -297,000 | |||||||||||||||
| interest expense | 4,000 | 656,000 | 494,000 | 527,000 | 538,000 | 537,000 | 530,000 | 523,000 | 533,000 | 533,000 | 526,000 | 525,000 | 530,000 | 529,000 | 523,000 | 537,000 | 689,000 | 680,000 | ||||||||||
| other income | 3,498,000 | -578,000 | 778,000 | -118,000 | 135,000 | 60,000 | -73,000 | 224,000 | 61,000 | -17,000 | -241,000 | 101,000 | 144,000 | 45,000 | 27,000 | 33,000 | 19,000 | 38,000 | -62,000 | -2,000 | -3,000 | -78,000 | -7,000 | -30,000 | -13,000 | 38,000 | 13,000 | 5,000 |
| total other income | -984,000 | -5,644,000 | -4,752,000 | -6,008,000 | -5,747,000 | -5,863,000 | -5,943,000 | -5,271,000 | -4,861,000 | -4,290,000 | -3,610,000 | -593,000 | 341,000 | 538,000 | 550,000 | 548,000 | 518,000 | 504,000 | 394,000 | 406,000 | 275,000 | -195,000 | -253,000 | -404,000 | -526,000 | -511,000 | -119,000 | 44,000 |
| income before income taxes | -2,332,000 | 4,159,000 | 36,636,000 | 20,326,000 | 10,846,000 | -9,355,000 | 15,240,000 | -8,200,000 | -11,738,000 | -15,208,000 | 3,275,000 | -16,601,000 | -14,348,000 | -16,594,000 | -2,371,000 | -10,344,000 | -13,062,000 | -16,193,000 | -7,456,000 | -10,298,000 | -23,089,000 | -16,245,000 | -9,040,000 | -8,247,000 | -7,650,000 | -8,266,000 | -4,778,000 | -4,693,000 |
| income taxes | 1,260,000 | 1,167,000 | 1,412,000 | 1,829,000 | 1,053,000 | 650,000 | 477,000 | 340,000 | 214,000 | 216,000 | 125,000 | 246,000 | 142,000 | 100,000 | 20,000 | 3,000 | 26,000 | 23,000 | 28,000 | 87,000 | ||||||||
| net income | -3,592,000 | 2,992,000 | 35,224,000 | 18,497,000 | 9,793,000 | -10,005,000 | 14,763,000 | -8,540,000 | -11,952,000 | -15,424,000 | 3,150,000 | -16,847,000 | -14,490,000 | -16,694,000 | -2,391,000 | -10,347,000 | -13,088,000 | -16,216,000 | -7,484,000 | -10,385,000 | -23,089,000 | -16,245,000 | -9,080,000 | -8,247,000 | -7,650,000 | -8,266,000 | -4,778,000 | -4,693,000 |
| yoy | -136.68% | -129.91% | 138.60% | -316.59% | -181.94% | -35.13% | 368.67% | -49.31% | -17.52% | -7.61% | -231.74% | 62.82% | 10.71% | 2.95% | -68.05% | -0.37% | -43.31% | -0.18% | -17.58% | 25.92% | 201.82% | 96.53% | 90.04% | 75.73% | ||||
| qoq | -220.05% | -91.51% | 90.43% | 88.88% | -197.88% | -167.77% | -272.87% | -28.55% | -22.51% | -589.65% | -118.70% | 16.27% | -13.20% | 598.20% | -76.89% | -20.94% | -19.29% | 116.68% | -27.93% | -55.02% | 42.13% | 78.91% | 10.10% | 7.80% | -7.45% | 73.00% | 1.81% | |
| net income margin % | -1.65% | 1.49% | 14.69% | 9.10% | 5.00% | -6.10% | 7.67% | -5.57% | -7.91% | -12.06% | 2.28% | -15.43% | -15.86% | -24.06% | -3.05% | -16.77% | -24.71% | -40.19% | -16.27% | -28.97% | -189.52% | -76.10% | -33.75% | -39.53% | -42.42% | -50.87% | -28.85% | -35.95% |
| other comprehensive income: | ||||||||||||||||||||||||||||
| foreign currency translation gain | 191,000 | -151,000 | 259,000 | -39,000 | -134,000 | 72,000 | 105,000 | 42,000 | ||||||||||||||||||||
| unrealized loss on investments | -22,000 | -9,000 | -45,000 | -143,000 | ||||||||||||||||||||||||
| total comprehensive income | -3,423,000 | 2,683,000 | 34,060,000 | 20,312,000 | 9,554,000 | |||||||||||||||||||||||
| net income per share | -0.34 | 0.51 | -0.29 | -0.41 | -0.53 | 0.13 | -0.6 | -0.53 | -0.61 | -0.08 | -0.38 | -0.48 | -0.6 | -0.26 | -0.39 | -0.88 | -0.67 | -0.38 | -0.34 | -0.32 | -0.35 | -0.1 | -0.22 | |||||
| basic | -0.12 | 0.1 | 1.19 | 0.62 | 0.33 | |||||||||||||||||||||||
| diluted | -0.12 | 0.1 | 1.15 | 0.6 | 0.32 | |||||||||||||||||||||||
| weighted-average shares outstanding: | ||||||||||||||||||||||||||||
| basic | 29,506,807 | 29,702,358 | 29,763,395 | 29,879,621 | 29,728,849 | |||||||||||||||||||||||
| diluted | 29,506,807 | 30,311,476 | 30,543,274 | 30,633,789 | 30,408,439 | |||||||||||||||||||||||
| foreign currency translation loss | -300,000 | -1,000 | -181,000 | -26,500 | -148,000 | |||||||||||||||||||||||
| unrealized gain on investments | -1,013,000 | 1,556,000 | -200,000 | -542,000 | 612,000 | 122,000 | -1,000 | 13,000 | -50,500 | -14,000 | -46,000 | 3,000 | -21,000 | -20,000 | -44,000 | -81,000 | -141,000 | 193,000 | 12,000 | 39,000 | 35,000 | |||||||
| other comprehensive loss: | ||||||||||||||||||||||||||||
| total comprehensive loss | -10,681,000 | 15,519,000 | -8,599,000 | -11,881,000 | -15,306,000 | 3,427,000 | -17,009,000 | -14,493,000 | -16,837,000 | -2,437,000 | -10,344,000 | -13,109,000 | -16,236,000 | -7,528,000 | -10,466,000 | -23,230,000 | -16,052,000 | -9,068,000 | -8,208,000 | -7,615,000 | -8,198,000 | -4,804,000 | -4,719,000 | |||||
| net income per share | -0.34 | 0.51 | -0.29 | -0.41 | -0.53 | 0.13 | -0.6 | -0.53 | -0.61 | -0.08 | -0.38 | -0.48 | -0.6 | -0.26 | -0.39 | -0.88 | -0.67 | -0.38 | -0.34 | -0.32 | -0.35 | -0.1 | -0.22 | |||||
| weighted-average common shares used to compute net income per share, basic and diluted | 29,615,166 | 29,302,154 | 29,365,968 | 29,229,922 | 29,089,950 | 28,071,748 | 28,226,345 | 27,594,874 | 27,517,268 | 27,262,979 | 27,300,377 | 27,230,044 | 27,144,361 | 26,073,418 | 26,835,603 | 26,289,272 | 24,165,875 | 23,804,452 | 23,940,430 | 23,753,647 | 23,441,560 | 14,579,662 | 21,361,739 | |||||
| interest income | -34,000 | -15,000 | -22,000 | -31,000 | -57,000 | -77,000 | -125,000 | -248,000 | -642,000 | -776,000 | -903,000 | -1,036,000 | -1,086,000 | -821,000 | -641,000 | |||||||||||||
| unrealized gain on short-term investments | 68,000 | |||||||||||||||||||||||||||
| selling and marketing | 7,978,250 | 11,312,000 | ||||||||||||||||||||||||||
| general and administrative | 1,375,750 | 2,153,000 | ||||||||||||||||||||||||||
| unrealized loss on short-term investments | -6,500 | -26,000 |
We provide you with 20 years income statements for Inspire Medical Systems stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Inspire Medical Systems stock. Explore the full financial landscape of Inspire Medical Systems stock with our expertly curated income statements.
The information provided in this report about Inspire Medical Systems stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.